Abstract 5737: Preclinical study of a novel long-acting receptor-biased rhIL-2 drug with sustained activation of cytotoxic T cells
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Peipei Cao, Biaxue Zhao, Jun Wang, Chenyang Jiang, Yu Zhuang, Bruce Y. Ma
Institution: Zonhon Biopharma Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409631545